China Shineway Pharmaceutical Group Limited
2877
Kedudukan dalam Saham
#11058
As an investment holding enterprise, China Shineway Pharmaceutical Group... As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
Harga Saham
$0.94153705
Modal Pasaran
$711.24M
Perubahan (1 hari)
-1.47%
Perubahan (1 tahun)
-95.11%
Negara
CN
Perdagangan China Shineway Pharmaceutical Group Limited (2877)
Kategori
Healthcare
Sejarah pecahan saham untuk China Shineway Pharmaceutical Group Limited (2877)
Saham China Shineway Pharmaceutical Group Limited (simbol: 2877) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham 2877 yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham 2877.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham 2877 yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham 2877.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
